IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis.
about
RE1-silencing transcription factor (REST) and REST-interacting LIM domain protein (RILP) affect P19CL6 differentiationIdentification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancerWnt/beta-catenin signaling: components, mechanisms, and diseasesUnraveling insulin-like growth factor binding protein-3 actions in human diseaseThe insulin-like growth factor system in cancerSmall is beautiful: insulin-like growth factors and their role in growth, development, and cancerCCAAT/enhancer-binding proteins (C/EBP)-α and -β are essential for ovulation, luteinization, and the expression of key target genesInsulin inhibits cardiac mesoderm, not mesendoderm, formation during cardiac differentiation of human pluripotent stem cells and modulation of canonical Wnt signaling can rescue this inhibitionSmad1 transcription factor integrates BMP2 and Wnt3a signals in migrating cardiac progenitor cells.Targeting insulin-like growth factor-I and insulin-like growth factor-binding protein-3 signaling pathways. A novel therapeutic approach for asthmaAberrant expression of a beta-catenin gain-of-function mutant induces hyperplastic transformation in the mouse cornea.Blocking the Wnt pathway, a unifying mechanism for an angiogenic inhibitor in the serine proteinase inhibitor family.Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approachInhibition of connective tissue growth factor overexpression in diabetic retinopathy by SERPINA3K via blocking the WNT/beta-catenin pathway.Gene Expression and Serum Cytokine Profiling of Low Stage CLL Identify WNT/PCP, Flt-3L/Flt-3 and CXCL9/CXCR3 as Regulators of Cell Proliferation, Survival and MigrationLEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosisProtection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3.Wnt11 promotes cardiomyocyte development by caspase-mediated suppression of canonical Wnt signalsEvolution of ancient functions in the vertebrate insulin-like growth factor system uncovered by study of duplicated salmonid fish genomes.Insulin-like growth factor binding proteins increase intracellular calcium levels in two different cell lines.Negative feedback regulation of Wnt signaling via N-linked fucosylation in zebrafish.IGF binding protein-4 is required for the growth effects of glucagon-like peptide-2 in murine intestineIdentification of a novel inhibitor of the canonical Wnt pathway.Development of glycoprotein capture-based label-free method for the high-throughput screening of differential glycoproteins in hepatocellular carcinoma.Visceral adiposity, insulin resistance and cancer risk.Mutation of IGFBP7 causes upregulation of BRAF/MEK/ERK pathway and familial retinal arterial macroaneurysmsIGF binding protein 2 supports the survival and cycling of hematopoietic stem cellsInsulin-like growth factor-1 receptor identifies a pool of human cardiac stem cells with superior therapeutic potential for myocardial regeneration.Key questions and answers about pregnancy-associated plasma protein-A.GATA-4 promotes myocardial transdifferentiation of mesenchymal stromal cells via up-regulating IGFBP-4.Hematopoietic progenitors are required for proper development of coronary vasculatureInsulin biosynthesis in neuronal progenitors derived from adult hippocampus and the olfactory bulb.Wnt signaling exerts an antiproliferative effect on adult cardiac progenitor cells through IGFBP3Therapeutic potential of a monoclonal antibody blocking the Wnt pathway in diabetic retinopathyMechanical Forces Reshape Differentiation Cues That Guide Cardiomyogenesis.MiR218 Modulates Wnt Signaling in Mouse Cardiac Stem Cells by Promoting Proliferation and Inhibiting Differentiation through a Positive Feedback LoopSecreted and transmembrane wnt inhibitors and activators.Lmo4 establishes rostral motor cortex projection neuron subtype diversity.SOX9 directly regulates IGFBP-4 in the intestinal epithelium.Assessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patients
P2860
Q24322741-EB1C66C6-E4C8-4C2A-99AF-F80209ABAE4EQ24604176-0327B106-654B-4731-8E48-43D479285E4AQ24630938-9CA90F0A-4A14-4D86-BB91-F612D9255BA9Q24650060-80169E5E-F0C9-4800-84FC-266D04680C3BQ27013945-55E4C5B7-CFA6-4C79-A7DA-DFA2FE102107Q30395770-10C6750F-926C-4CA4-AE23-170F35608F40Q30426060-9282792A-FABE-4A9A-B758-4BFC86892E87Q30536707-6B376715-5D52-4F55-90D0-3373B0A759C5Q30578883-B66E0010-0013-4858-A802-2C3EFE8649DDQ33756365-518CFFCA-12DF-45C0-AACA-833F19169AA3Q33763816-316FAFC7-CDE7-4CD3-A035-923F24FF0FD3Q33859420-E337668A-5E0A-45E9-9B0A-D8A6824E4F64Q33925323-234A68C0-ABEB-4717-BC53-0BA152582952Q33930328-68049454-29E2-412C-8446-48A29693AD36Q34219505-F3C8F0F6-363B-4CB9-9FD2-1F5A067CAEA3Q34282335-5D8D658B-398D-4456-B1F5-AA320BF46E53Q34335696-6783A07D-C1A8-46DB-ABD2-328E73EC8D5EQ34484392-D4ED8EDB-9FAD-4F7D-A6C8-4AF069A1DE78Q34567014-A2E42F89-45CC-481F-AB78-8C3913211C7AQ34634999-B0409EF0-50C2-4FAE-8F3E-793F9EA7149FQ34651389-5EB25A4B-F163-450E-B535-2E937B487F74Q34982361-99A9F2E4-B866-4A6A-9345-B3C0724878B1Q35096644-C2D19BFB-B073-4A78-B8BB-22ABCCE3C2CBQ35098547-71203EFA-6A1B-4506-A573-BDE3DAF8B0D0Q35133640-926F52DE-C3D1-4F61-B1C9-339B8B2D75F3Q35161616-4BBEE88D-F5D0-48D7-BA0F-1B80A2883060Q35230193-A0D0B223-940F-415D-A2E2-5019D1A031F1Q35820632-502E87AA-5822-4EC0-AFC3-D3238397DAA0Q35947007-D1FE4889-C529-4531-ACC5-F38CB1AD7FD0Q36005774-B7074D69-FC2F-4123-9AFA-0C27CBE68287Q36021595-8FBC779D-5B9F-439C-B05A-917DD4993A97Q36038860-CB6BB195-2273-4ABB-B717-202E277F9BC3Q36063682-FD8FD26E-9E86-4D06-8815-AF45711D5C9CQ36339514-B4722FD7-AB16-4440-B2BD-4192E14176F1Q36550789-61C78DFE-41F2-47D2-9C7C-3E366B382F5DQ36565103-CF748A02-7415-4CB4-A9AA-592D1EE0367CQ36626700-1AD5A8BA-48EA-46F9-B2D4-E8FABD0CE974Q36974455-212F2929-A415-4E4B-9392-8B9054A42285Q37051549-DC566A11-5E69-4194-85A3-9BF25036EB48Q37064715-EFA6D83A-D72B-46D1-A75F-090268FCD55C
P2860
IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis.
@en
IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis.
@nl
type
label
IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis.
@en
IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis.
@nl
prefLabel
IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis.
@en
IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis.
@nl
P2093
P50
P921
P356
P1433
P1476
IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis.
@en
P2093
Akihiro Umezawa
Akira Kikuchi
Atsuhiko T Naito
Hiroo Ueno
Hiroyuki Ikeda
Ichiro Shiojima
Jun-ichiro Nishi
Masashi Yoshida
Toshio Nagai
Weidong Zhu
P2888
P304
P356
10.1038/NATURE07027
P407
P577
2008-06-04T00:00:00Z
P5875
P6179
1017714421